SmartTrade Technologies has acquired Celoxica for an undisclosed amount, adding market-access and order-execution infrastructure to a business spanning OTC trading and payments. The purchase brings venue access and in-line pre-trade risk into the same provider group as smartTrade's workflow, pricing and distribution tools.
Execution meets trading workflows
Celoxica supplies hardware-accelerated execution technology used across more than 80 venues worldwide. Its customers include algorithmic-trading desks and quantitative trading firms, as well as hedge funds, prime brokers and banks. SmartTrade, meanwhile, develops electronic trading and payments software for FX, FX derivatives and payments.
The companies sit at different points in the trading stack: smartTrade handles workflow, pricing and distribution, while Celoxica focuses on accessing markets, executing orders and applying pre-trade controls in-line. Celoxica's FPGA systems are designed for nanosecond-level execution; its software-based systems run at single-digit microsecond latency. David Vincent, chief executive officer and co-founder of smartTrade, said the combined businesses could offer clients more value than either could alone.
The earlier acquisition and UK results
The deal follows smartTrade's acquisition of kACE Financial, a pricing and analytics specialist for FX and rates derivatives. Formerly known as Fenics, kACE was bought from BGC Group after an agreement in December 2025 and a completion in January. The transaction was valued at as much as $119 million.
Corporate filings show smartTrade's UK subsidiary reported net profit of £3.39 million for the year ending March 2026, up 22%. The filings attributed the increase to widening margins and European sales growth. The Celoxica purchase is intended to give smartTrade's more than 250 clients access to its execution technology, while Celoxica's customers may be able to use smartTrade tools for connectivity, aggregation, distribution, order management, analytics and AI.
Jean-Marc Bouhelier, Celoxica's general manager, will continue to run the business and join smartTrade's executive committee. The companies say client relationships, contracts, support and daily service will not change. Finance Magnates also reported that futures-focused Trading Technologies bought equities and equity-options routing specialist TRAFiX in September, another expansion towards a broader multi-asset offering.
What an operations team should check
Trading and infrastructure teams will need to clarify how Celoxica's execution and risk components connect to existing workflow, pricing and order-management systems. The available details do not specify the integration architecture or whether clients will need to change connectivity, order-state handling or monitoring. Those points matter when assessing routing behaviour and reconciliation across the combined stack.
Operators should ask how the stated latency figures are measured and whether the acquisition changes deployment or support arrangements. They should also confirm which entity owns incident response for each component and how any changes affect client contracts. The companies say support and day-to-day service remain unchanged, but have not disclosed the deal value or further integration details.
Platforms · Software · Providers · Markets